Sabar Karimah Es bought CAPR
April 2, 2026 · Form 4 insider transaction
Sabar Karimah Es bought 7,529 shares of Capricor Therapeutics, Inc. at $3.18 per share, a transaction worth $23.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,529
Price
$3.18
Total value
$23.9K
InsiderSabar Karimah Es
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 2, 2026
Filing dateApril 3, 2026
Shares owned after7,529
OwnershipDirect
10b5-1 planNo
AmendedNo